In the global medical devices industry, there were 168 M&A deals announced in Q3 2024, worth a total value of $14.4bn, according to GlobalData’s Deals Database. The $3.8bn acquisition of Baxter International by Carlyle Group was the industry’s largest disclosed deal. GlobalData’s ²ÊÉñvlllÕù°Ôs Industry Mergers and Acquisitions Deals by Top Themes in Q3 2024 report helps understand the pivotal themes steering M&A activity in the industry.
In value terms, M&A activity decreased by 32% in Q3 2024 compared with the previous quarter’s total of $21.2bn and rose by 247% as compared to Q3 2023. Related deal volume increased by 30% in Q3 2024 versus the previous quarter and was 47% higher than in Q3 2023.
Notably, foreign direct investments (fdi)-related deals accounted for a 39% share of the global medical devices industry’s M&A activity in Q3 2024, up 33% over the previous quarter.
The top-ranked financial advisors supporting these M&A deals in 9M 2024 were Jefferies Financial Group; Evercore; Stifel Financial with 6, 4, 4 deals respectively.
The top-ranked legal advisors supporting these M&A deals in 9M 2024 were Kirkland & Ellis; CMS Legal Services EEIG; Weil, Gotshal & Manges with 14, 8, 6 deals respectively.
For further understanding of GlobalData's ²ÊÉñvlllÕù°Ôs Industry Mergers And Acquisitions Deals By Top Themes In Q3 2024 – Strategic Intelligence,
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.